Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A
General Information (adopted from Orphanet):
Synonyms, Signs: |
MOCODA SULFITE OXIDASE, XANTHINE DEHYDROGENASE, AND ALDEHYDE OXIDASE, COMBINED DEFICIENCY OF Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase type A MOCOD type A |
Number of Symptoms | 54 |
OrphanetNr: | 308386 |
OMIM Id: |
252150
|
ICD-10: |
E72.1 |
UMLs: |
|
MeSH: |
|
MedDRA: |
|
Snomed: |
|
Prevalence, inheritance and age of onset:
Prevalence: | No data available. |
Inheritance: |
Autosomal recessive inheritance [Omim] |
Age of onset: |
|
Disease classification (adopted from Orphanet):
Parent Diseases: |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency
-Rare developmental defect during embryogenesis -Rare eye disease -Rare genetic disease -Rare neurologic disease |
Symptom Information:
|
(HPO:0011943) | Increased urinary thiosulfate | 1 / 7739 | ||||
|
(HPO:0003166) | Increased urinary taurine | 5 / 7739 | ||||
|
(HPO:0011935) | Decreased urinary urate | 2 / 7739 | ||||
|
(HPO:0003606) | Absent urinary urothione | 1 / 7739 | ||||
|
(HPO:0011942) | Increased urinary sulfite | 2 / 7739 | ||||
|
(HPO:0000804) | Xanthine nephrolithiasis | 4 / 7739 | ||||
|
(HPO:0003359) | Decreased urinary sulfate | 2 / 7739 | ||||
|
(HPO:0000293) | Full cheeks | 85 / 7739 | ||||
|
(HPO:0000252) | Microcephaly | 832 / 7739 | ||||
|
(HPO:0003196) | Short nose | 264 / 7739 | ||||
|
(HPO:0000276) | Long face | 109 / 7739 | ||||
|
(HPO:0002007) | Frontal bossing | 366 / 7739 | ||||
|
(HPO:0000343) | Long philtrum | 262 / 7739 | ||||
|
(HPO:0000316) | Hypertelorism | 644 / 7739 | ||||
|
(HPO:0012471) | Thick vermilion border | 115 / 7739 | ||||
|
(HPO:0000256) | Macrocephaly | 298 / 7739 | ||||
|
(HPO:0011527) | Lentiglobus | 3 / 7739 | ||||
|
(HPO:0001142) | Lenticonus | 4 / 7739 | ||||
|
(HPO:0001083) | Ectopia lentis | 45 / 7739 | ||||
|
(HPO:0008063) | Aplasia/Hypoplasia of the lens | 3 / 7739 | ||||
|
(HPO:0000639) | Nystagmus | 555 / 7739 | ||||
|
(HPO:0001249) | Intellectual disability | 1089 / 7739 | ||||
|
(HPO:0001276) | Hypertonia | 317 / 7739 | ||||
|
(HPO:0001285) | Spastic tetraparesis | 29 / 7739 | ||||
|
(HPO:0003739) | Myoclonic spasms | 7 / 7739 | ||||
|
(HPO:0002510) | Spastic tetraplegia | 54 / 7739 | ||||
|
(HPO:0011096) | Peripheral demyelination | 28 / 7739 | ||||
|
(HPO:0003447) | Axonal loss | 11 / 7739 | ||||
|
(HPO:0001250) | Seizures | 1245 / 7739 | ||||
|
(HPO:0002179) | Opisthotonus | 35 / 7739 | ||||
|
(HPO:0011968) | Feeding difficulties | 240 / 7739 | ||||
|
(HPO:0008872) | Feeding difficulties in infancy | 153 / 7739 | ||||
|
(HPO:0001510) | Growth delay | 295 / 7739 | ||||
|
(HPO:0003534) | Reduced xanthine dehydrogenase activity | 2 / 7739 | ||||
|
(HPO:0010934) | Xanthinuria | 4 / 7739 | ||||
|
(HPO:0011814) | Increased urinary hypoxanthine | 2 / 7739 | ||||
|
(HPO:0003643) | Sulfite oxidase deficiency | 2 / 7739 | ||||
|
(HPO:0002932) | Aldehyde oxidase deficiency | 1 / 7739 | ||||
|
(HPO:0003570) | Molybdenum cofactor deficiency | 3 / 7739 | ||||
|
(HPO:0003537) | Hypouricemia | 13 / 7739 | ||||
|
(OMIM) | Absent or delayed psychomotor development, severe | 2 / 7739 | ||||
|
(HPO:0002171) | Gliosis | 48 / 7739 | ||||
|
(OMIM) | Intractable seizures | 12 / 7739 | ||||
|
(HPO:0002059) | Cerebral atrophy | 171 / 7739 | ||||
|
(OMIM) | Asymmetric skull | 6 / 7739 | ||||
|
(OMIM) | Cystic lysis of the deep white matter | 2 / 7739 | ||||
|
(OMIM) | Decreased xanthine dehydrogenase activity | 2 / 7739 | ||||
|
(HPO:0002079) | Hypoplasia of the corpus callosum | 161 / 7739 | ||||
|
(OMIM) | Increased urinary S-sulfocysteine | 2 / 7739 | ||||
|
(HPO:0000007) | Autosomal recessive inheritance | 2538 / 7739 | ||||
|
(HPO:0002119) | Ventriculomegaly | 253 / 7739 | ||||
|
(OMIM) | Elongated palpebral fissures | 2 / 7739 | ||||
|
(OMIM) | Decreased sulfite oxidase activity | 2 / 7739 | ||||
|
(HPO:0003676) | Progressive disorder | 148 / 7739 |
Associated genes:
ClinVar (via SNiPA)
Gene symbol | Variation | Clinical significance | Reference |
---|
Additional Information:
Description: (OMIM) |
Molybdenum cofactor deficiency (MOCOD) is a rare autosomal recessive metabolic disorder characterized by onset in infancy of poor feeding, intractable seizures, and severe psychomotor retardation. Characteristic biochemical abnormalities include decreased serum uric acid and increased urine sulfite levels ... |
Diagnosis OMIM |
Wadman et al. (1983) called attention to a very simple screening test for urinary sulfite, which was originally developed for the semiquantitative determination of sulfite in wine and fruit juices and is available as a 'strip test.' Aukett ... |
Clinical Description OMIM |
Duran et al. (1978) reported a female infant with a combination of sulfite oxidase deficiency (272300) and xanthine oxidase deficiency (278300). She presented at age 10 days with poor feeding, tonic-clonic seizures, EEG abnormalities, and dysmorphic features, including ... |
Molecular genetics OMIM |
In 2 unrelated patients with molybdenum cofactor deficiency of complementation group A, Reiss et al. (1998) identified 2 different homozygous truncating mutations in the MOCS1 gene (603707.0001 and 603707.0002); one mutation occurred in the MOCS1A transcript and the ... |